Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study

Introduction: Surgical treatment of vulvar squamous cell carcinoma (VSCC) has evolved in the 21st century following the implementation of radical local excision, sentinel lymph node biopsy, and reconstructive techniques. Population-level studies focusing on survival trends of surgically treated VSCC patients are scarce. Methods: All primary VSCC surgeries performed in Finland between 2000 and 2021 were identified from the Care Register for Health Care. Historical cohorts representing radical and personalized surgical eras [2000–2005 ( n = 301) and 2014–2019 ( n = 359)] were compared. Primary outcome was overall survival (OS); secondary outcomes were disease-specific survival (DSS), progression-free survival (PFS), postoperative complications, reoperations, and adjuvant treatment delays. Survival analyses were performed using Kaplan-Meier estimates, and multivariable Cox proportional hazards models adjusted for Charlson Comorbidity Index (CCI) and adjuvant treatment. Results: Personalized surgery cohort demonstrated significantly improved 2-year OS (67.1% vs 77.4%; p = 0.003) and DSS (74.2% vs 82.6%; p = 0.009) compared to the radical surgery cohort. After adjusting for adjuvant treatment and CCI score, personalized surgery cohort was independently associated with reduced all-cause mortality (aHR 0.4 (0.3–0.6); p < 0.001), disease-specific mortality (aHR 0.4 (0.3–0.6); p < 0.001), and risk of recurrence/death (aHR 0.7 (0.5–0.9); p = 0.008). Increased rates of postoperative complications (7.6% vs 20.3%; p < 0.001) and reoperations (5.6% vs 10.0%; p = 0.039) were observed in the personalized surgery cohort; treatment delays were not increased. Conclusions: Personalized surgical management, likely together with more accurate targeting of adjuvant treatment, has led to improved survival in VSCC patients undergoing primary surgery. Increased reoperation rate may reflect increased surgical complexity, more proactive complication management, and/or improved documentation practices.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology
Published
2026-09-21
DOI
https://doi.org/10.1016/j.ygyno.2026.09.009
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study

Reita H. Nyberg, Milla K Mörsky, Sakke Purolainen, Ilkka S. Kaartinen et al.
Gynecologic Oncology
Endometrial and Cervical Cancer Treatments
article

Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study

Reita H. Nyberg, Milla K Mörsky, Sakke Purolainen, Ilkka S. Kaartinen, Ville M. Mattila, Synnöve Staff
article en

Abstract

Introduction: Surgical treatment of vulvar squamous cell carcinoma (VSCC) has evolved in the 21st century following the implementation of radical local excision, sentinel lymph node biopsy, and reconstructive techniques. Population-level studies focusing on survival trends of surgically treated VSCC patients are scarce. Methods: All primary VSCC surgeries performed in Finland between 2000 and 2021 were identified from the Care Register for Health Care. Historical cohorts representing radical and personalized surgical eras [2000–2005 ( n = 301) and 2014–2019 ( n = 359)] were compared. Primary outcome was overall survival (OS); secondary outcomes were disease-specific survival (DSS), progression-free survival (PFS), postoperative complications, reoperations, and adjuvant treatment delays. Survival analyses were performed using Kaplan-Meier estimates, and multivariable Cox proportional hazards models adjusted for Charlson Comorbidity Index (CCI) and adjuvant treatment. Results: Personalized surgery cohort demonstrated significantly improved 2-year OS (67.1% vs 77.4%; p = 0.003) and DSS (74.2% vs 82.6%; p = 0.009) compared to the radical surgery cohort. After adjusting for adjuvant treatment and CCI score, personalized surgery cohort was independently associated with reduced all-cause mortality (aHR 0.4 (0.3–0.6); p < 0.001), disease-specific mortality (aHR 0.4 (0.3–0.6); p < 0.001), and risk of recurrence/death (aHR 0.7 (0.5–0.9); p = 0.008). Increased rates of postoperative complications (7.6% vs 20.3%; p < 0.001) and reoperations (5.6% vs 10.0%; p = 0.039) were observed in the personalized surgery cohort; treatment delays were not increased. Conclusions: Personalized surgical management, likely together with more accurate targeting of adjuvant treatment, has led to improved survival in VSCC patients undergoing primary surgery. Increased reoperation rate may reflect increased surgical complexity, more proactive complication management, and/or improved documentation practices.

Gynecologic OncologyVol. 213
Tampere University of Applied Sciences (FI), Tampere University (FI), Pirkanmaa Hospital District (FI), Tampere University Hospital (FI), Tampere University (FI)
Openalex Percentile: Top 8%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.